SEARCH

SEARCH BY CITATION

This editorial comments on 2 companion articles that present the preliminary results of the American Society of Clinical Oncology (ASCO) breast cancer registry (BCR) pilot program. The ASCO BCR demonstrates how registry data can be collected prospectively for quality assessment purposes as well as the creation of treatment and survivorship care plans in a way that is acceptable to oncology clinicians and patients.